Home / Business and Economy / Bayer Boosts US Manufacturing with Ohio Site
Bayer Boosts US Manufacturing with Ohio Site
3 Oct
Summary
- Bayer AG plans a $2.2 billion investment for a new Ohio manufacturing site.
- This investment signifies European pharmaceutical companies responding to US pressure.
- The new facility will focus on producing key pharmaceutical components.
Bayer AG has announced plans for a substantial $2.2 billion investment to establish a new manufacturing facility in Ohio. This significant financial commitment marks a notable development within the pharmaceutical sector.
The decision by Bayer AG aligns with broader trends, as European pharmaceutical companies face increasing pressure from the US administration. These companies are being urged to lower drug prices and enhance their manufacturing presence within the United States.
This new Ohio-based site is slated to focus on the production of critical components for pharmaceutical products. The investment is expected to reinforce US manufacturing capacity and contribute to the pharmaceutical supply chain.
